Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Emmanuel

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Reviews on Recent Clinical Trials|June 21, 2011
Sugammadex, a promising reversal drug. A review of clinical trialsIra Makri, Artemisia Papadima, Aimilia Lafioniati, et al.
BMC Medical Education|October 24, 2024
A survey of essential anatomy from the perspective of anesthesiology, emergency medicine, obstetrics and gynecology, and orthopedics resident physiciansDerek J Harmon, Mark H Hankin, James R Martindale, et al.
JAMA Oncology|December 30, 2021
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Jonathan M Kocarnik, Kelly Compton, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Reviews on Recent Clinical Trials|June 21, 2011
Sugammadex, a promising reversal drug. A review of clinical trialsIra Makri, Artemisia Papadima, Aimilia Lafioniati, et al.
BMC Medical Education|October 24, 2024
A survey of essential anatomy from the perspective of anesthesiology, emergency medicine, obstetrics and gynecology, and orthopedics resident physiciansDerek J Harmon, Mark H Hankin, James R Martindale, et al.
JAMA Oncology|December 30, 2021
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Jonathan M Kocarnik, Kelly Compton, et al.
Pageof 3